​

Alpha Tau Medical (DRTS) Stock Forecast, Price Target & Predictions

OverviewOwnershipChart

DRTS Stock Forecast

Alpha Tau Medical (DRTS) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $13.33, with a high of $17.00 and a low of $8.00. This represents a 37.71% increase from the last price of $9.68.

- $4 $8 $12 $16 $20 High: $17 Avg: $13.33 Low: $8 Last Closed Price: $9.68

DRTS Stock Rating

Alpha Tau Medical stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (83.33%), 1 Hold (16.67%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 1 5 0 Strong Sell Sell Hold Buy Strong Buy

DRTS Price Target Upside V Benchmarks

TypeNameUpside
StockAlpha Tau Medical37.71%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts346
Avg Price Target$13.33$13.75$12.67
Last Closing Price$9.68$9.68$9.68
Upside/Downside37.71%42.05%30.89%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 26131--5
May, 26-31--4
Apr, 26-31--4
Mar, 2613---4
Feb, 2613---4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 04, 2026Barclays$17.00$10.5860.68%75.62%
May 28, 2026Lukas ShumwayBarclays$15.00$10.2945.77%54.96%
May 19, 2026Piper Sandler$8.00$10.03-20.24%-17.36%
May 12, 2026H.C. Wainwright$15.00$10.3445.07%54.96%
Feb 24, 2026Yi ChenH.C. Wainwright$12.00$7.5060.00%23.97%
Sep 03, 2025Yi ChenH.C. Wainwright$9.00$3.59150.70%-7.02%
May 21, 2024Jason BednarPiper Sandler$7.00$2.91140.55%-27.69%
Nov 23, 2022Piper Sandler$12.00$3.75220.00%23.97%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 04, 2026BarclaysOverweightOverweighthold
Jun 03, 2026H.C. WainwrightBuyBuyhold
May 28, 2026BarclaysOverweightinitialise
May 19, 2026Piper SandlerNeutralNeutralhold
May 12, 2026H.C. WainwrightBuyBuyhold
Feb 24, 2026H.C. WainwrightBuyBuyhold
Dec 10, 2025H.C. WainwrightBuyBuyhold
Sep 03, 2025H.C. WainwrightBuyBuyhold
Oct 11, 2024H.C. WainwrightBuyBuyhold
Aug 21, 2024H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.42-----
Avg Forecast$-0.43$-0.42$-0.45$-0.26$-0.45$0.20
High Forecast$-0.41$-0.41$-0.45$-0.26$-0.45$0.20
Low Forecast$-0.44$-0.43$-0.46$-0.26$-0.45$0.20
Surprise %-2.33%-----

Revenue Forecast

$0 $30M $60M $90M $120M $150M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast-$212.50K$1.05M$20.20M$15.71M$131.10M
High Forecast-$212.50K$1.05M$20.69M$15.71M$131.10M
Low Forecast-$212.50K$1.05M$19.72M$15.71M$131.10M
Surprise %------

Net Income Forecast

$-35M $-25M $-15M $-5M $5M $15M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-29.16M-----
Avg Forecast$-29.93M$-29.36M$-31.24M$-17.99M$-31.22M$13.88M
High Forecast$-28.57M$-28.70M$-31.24M$-17.99M$-31.22M$13.88M
Low Forecast$-30.62M$-30.01M$-31.87M$-17.99M$-31.22M$13.88M
Surprise %-2.60%-----

DRTS Forecast FAQ

Is Alpha Tau Medical stock a buy?

Alpha Tau Medical stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Alpha Tau Medical is a favorable investment for most analysts.

What is Alpha Tau Medical's price target?

Alpha Tau Medical's price target, set by 6 Wall Street analysts, averages $13.33 over the next 12 months. The price target range spans from $8 at the low end to $17 at the high end, suggesting a potential 37.71% change from the previous closing price of $9.68.

How does Alpha Tau Medical stock forecast compare to its benchmarks?

Alpha Tau Medical's stock forecast shows a 37.71% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Alpha Tau Medical over the past three months?

  • June 2026: 20.00% Strong Buy, 60.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 0% Strong Buy, 75.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 0% Strong Buy, 75.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.

What is Alpha Tau Medical’s EPS forecast?

Alpha Tau Medical's average annual EPS forecast for its fiscal year ending in December 2024 is $-0.42, marking a 0% decrease from the reported $-0.42 in 2023. Estimates for the following years are $-0.45 in 2025, $-0.26 in 2026, $-0.45 in 2027, and $0.2 in 2028.

What is Alpha Tau Medical’s revenue forecast?

Alpha Tau Medical's average annual revenue forecast for its fiscal year ending in December 2024 is $212.5K, reflecting a 0% decrease from the reported $0 in 2023. The forecast for 2025 is $1.05M, followed by $20.2M for 2026, $15.7M for 2027, and $131.1M for 2028.

What is Alpha Tau Medical’s net income forecast?

Alpha Tau Medical's net income forecast for the fiscal year ending in December 2024 stands at $-29.355M, representing an 0.68% increase from the reported $-29.157M in 2023. Projections indicate $-31.244M in 2025, $-17.993M in 2026, $-31.22M in 2027, and $13.88M in 2028.